Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022
CONCLUSION: Most of our results were consistent with the specification, but some new signals of adverse reactions such as acute pancreatitis were not included. Therefore, further studies are needed to validate unlabeled adverse reactions and provide important support for clinical monitoring and risk identification of metformin.PMID:38269492 | DOI:10.1080/17512433.2024.2306223 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - January 25, 2024 Category: Drugs & Pharmacology Authors: Yikuan Du Jinfeng Zhu Zhuoming Guo Zhenjie Wang Yuni Wang Mianda Hu Lingzhi Zhang Yurong Yang Jinjin Wang Yixing Huang Peiying Huang Mianhai Chen Bo Chen Chun Yang Source Type: research

Efficacy of pharmacological agents for the management of treatment-resistant schizophrenia: a network meta-analysis
CONCLUSION: Escitalopram augmentation of antipsychotics appears to be the most efficacious treatment with moderate certainty of evidence among the available pharmacological interventions.PROSPERO REGISTRATION: CRD42022380292.PMID:38269529 | DOI:10.1080/17512433.2024.2310715 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - January 25, 2024 Category: Drugs & Pharmacology Authors: Archana Mishra Rituparna Maiti Biswa Ranjan Mishra Anand Srinivasan Source Type: research

Revolutionizing diabetes care: unveiling tirzepatide's potential in glycemic control and beyond
Expert Rev Clin Pharmacol. 2024 Jan 24:1-12. doi: 10.1080/17512433.2024.2310070. Online ahead of print.ABSTRACTINTRODUCTION: Diabetes is a global public health challenge with rising prevalence. This review explores current diabetes understanding, diagnostic and management guidelines, economic impact, and lifestyle modifications as the primary approach.AREAS COVERED: Focusing on pharmacological interventions, we discuss the roles of GLP-1 agonists and GLP/GIP agonists in diabetes management and cardiovascular risk reduction. Tirzepatide, a novel medication, is highlighted for its unique mechanism of action. Clinical trials ...
Source: Expert Review of Clinical Pharmacology - January 24, 2024 Category: Drugs & Pharmacology Authors: Aayushi Sood Purnoor Kaur Omar Syed Akshit Sood Wilbert S Aronow Benjamin Borokhovsky Vishal Bhatia Rahul Gupta Source Type: research

Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
Expert Rev Clin Pharmacol. 2024 Jan 22:1-11. doi: 10.1080/17512433.2024.2307418. Online ahead of print.ABSTRACTINTRODUCTION: The technological advances of sequencing methods during the past 20 years have fuelled the generation of large amounts of sequencing data that comprise common variations, as well as millions of rare and personal variants that would not be identified by conventional genotyping. While comprehensive sequencing is technically feasible, its clinical utility for guiding personalized treatment decisions remains controversial.AREAS COVERED: We discuss the opportunities and challenges of comprehensive sequenc...
Source: Expert Review of Clinical Pharmacology - January 22, 2024 Category: Drugs & Pharmacology Authors: Yitian Zhou Volker M Lauschke Source Type: research

A preliminary study on plasma concentration, short-term efficacy, and safety profile of dolutegravir in Chinese people with HIV
CONCLUSION: Preliminary findings suggest higher DTG plasma concentrations in Chinese PWH compared to Western populations, with promising short-term efficacy and safety.PMID:38247657 | DOI:10.1080/17512433.2024.2308664 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - January 22, 2024 Category: Drugs & Pharmacology Authors: Dongsheng Li Ran Xiao Qiang Fu Xiaojing Song Yang Han Xiaoli Du Taisheng Li Source Type: research

Comparative effectiveness and safety of inhaled corticosteroid plus long-acting β < sub > 2 < /sub > -agonist fixed-dose combinations vs. long-acting muscarinic antagonist in bronchiectasis
CONCLUSION: Our findings provide important evidence on the effectiveness and safety of ICS/LABA FDC compared with LAMA for bronchiectasis. BEC/FOR and BUD/FOR were associated with better outcomes than FLU/SAL.PMID:38224017 | DOI:10.1080/17512433.2024.2306218 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - January 15, 2024 Category: Drugs & Pharmacology Authors: Vincent Yi-Fong Su Ting-Lin Ding Yuh-Lih Chang Yueh-Ching Chou Hsuen-En Hwang Chian-Ying Chou Chia-Chen Hsu Source Type: research

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Expert Rev Clin Pharmacol. 2024 Jan-Jun;17(2):131-142. doi: 10.1080/17512433.2024.2305798. Epub 2024 Jan 29.ABSTRACTINTRODUCTION: Kratom (Mitragyna speciosa) has generated substantial clinical and scientific interest as a complex natural product. Its predominant alkaloid mitragynine and several stereoisomers have been studied for activity in opioid, adrenergic, and serotonin receptors. While awaiting clinical trial results, the pre-clinical evidence suggests a range of potential therapeutic applications for kratom with careful consideration of potential adverse effects.AREAS COVERED: The focus of this review is on the phar...
Source: Expert Review of Clinical Pharmacology - January 13, 2024 Category: Drugs & Pharmacology Authors: Christopher R McCurdy Abhisheak Sharma Kirsten E Smith Charles A Veltri Stephanie T Weiss Charles M White Oliver Grundmann Source Type: research

Biomarker discovery in acetaminophen hepatotoxicity: leveraging single-cell transcriptomics and mechanistic insight
Expert Rev Clin Pharmacol. 2024 Jan-Jun;17(2):143-155. doi: 10.1080/17512433.2024.2306219. Epub 2024 Jan 29.ABSTRACTINTRODUCTION: Acetaminophen (APAP) overdose is the leading cause of drug-induced liver injury and can cause a rapid progression to acute liver failure (ALF). Therefore, the identification of prognostic biomarkers to determine which patients will require a liver transplant is critical for APAP-induced ALF.AREAS COVERED: We begin by relating the mechanistic investigations in mouse models of APAP hepatotoxicity to the human APAP overdose pathophysiology. We draw insights from the established sequence of molecula...
Source: Expert Review of Clinical Pharmacology - January 13, 2024 Category: Drugs & Pharmacology Authors: David S Umbaugh Hartmut Jaeschke Source Type: research

Clinical trial design for assessing hypertension medications: are critical circadian chronopharmacological principles being taking into account?
Expert Rev Clin Pharmacol. 2024 Jan-Jun;17(2):119-130. doi: 10.1080/17512433.2024.2304015. Epub 2024 Jan 29.ABSTRACTINTRODUCTION: Clinical hypertension trials typically rely on homeostatic principles, including single time-of-day office blood pressure (BP) measurements (OBPM), rather than circadian chronopharmacological principles, including ambulatory monitoring (ABPM) done around-the-clock to derive the asleep systolic BP (SBP) mean and sleep-time relative SBP decline - jointly the strongest prognosticators of cardiovascular disease (CVD) risk and true definition of hypertension - to qualify participants and assess outco...
Source: Expert Review of Clinical Pharmacology - January 10, 2024 Category: Drugs & Pharmacology Authors: Ram ón C Hermida Michael H Smolensky Artemio Moj ón Jos é R Fernández Source Type: research

Artificial intelligence-based model for dose prediction of sertraline in adolescents: a real-world study
CONCLUSION: The AI-based dose prediction model of sertraline in adolescents with depression had a good prediction ability, which provides guidance for clinicians to propose the optimal medication regimen.PMID:38197873 | DOI:10.1080/17512433.2024.2304009 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - January 10, 2024 Category: Drugs & Pharmacology Authors: Ran Fu Ze Yu Chunhua Zhou Jinyuan Zhang Fei Gao Donghan Wang Xin Hao Xiaolu Pang Jing Yu Source Type: research

The future of pharmacology education: a global outlook
Expert Rev Clin Pharmacol. 2024 Jan-Jun;17(2):115-118. doi: 10.1080/17512433.2024.2302602. Epub 2024 Jan 29.NO ABSTRACTPMID:38192241 | DOI:10.1080/17512433.2024.2302602 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - January 9, 2024 Category: Drugs & Pharmacology Authors: Clare Guilding Roisin Kelly-Laubscher Paul White Source Type: research

The future of pharmacology education: a global outlook
Expert Rev Clin Pharmacol. 2024 Jan 9:1-4. doi: 10.1080/17512433.2024.2302602. Online ahead of print.NO ABSTRACTPMID:38192241 | DOI:10.1080/17512433.2024.2302602 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - January 9, 2024 Category: Drugs & Pharmacology Authors: Clare Guilding Roisin Kelly-Laubscher Paul White Source Type: research

Artificial intelligence and machine learning in clinical pharmacological research
CONCLUSIONS: ML, and AI in general, is increasingly being used in various research areas within clinical pharmacology. This report presents specific examples of applications and highlights the most used ML methods.PMID:38165148 | DOI:10.1080/17512433.2023.2294005 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - January 2, 2024 Category: Drugs & Pharmacology Authors: Benjamin Mayer Dario Kringel J örn Lötsch Source Type: research